IRIS
GIACOMELLI, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.929
AS - Asia 11.627
EU - Europa 11.108
SA - Sud America 1.163
AF - Africa 150
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 33
Totale 44.050
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.728
SG - Singapore 4.747
CN - Cina 2.631
IE - Irlanda 2.538
RU - Federazione Russa 2.099
TR - Turchia 1.522
SE - Svezia 1.148
IT - Italia 1.137
HK - Hong Kong 1.117
DE - Germania 1.060
BR - Brasile 1.013
VN - Vietnam 938
UA - Ucraina 831
GB - Regno Unito 738
FR - Francia 601
FI - Finlandia 393
IN - India 218
NL - Olanda 216
CA - Canada 119
JP - Giappone 100
BE - Belgio 64
BD - Bangladesh 62
AR - Argentina 57
ZA - Sudafrica 50
MX - Messico 49
ES - Italia 47
PL - Polonia 39
IQ - Iraq 36
EU - Europa 34
PK - Pakistan 28
RO - Romania 27
ID - Indonesia 26
AU - Australia 24
CZ - Repubblica Ceca 24
LT - Lituania 22
KR - Corea 21
VE - Venezuela 20
EC - Ecuador 18
GR - Grecia 18
MA - Marocco 17
MY - Malesia 17
AT - Austria 16
CO - Colombia 16
PH - Filippine 16
CH - Svizzera 15
EG - Egitto 15
DZ - Algeria 14
JO - Giordania 13
NP - Nepal 13
PT - Portogallo 13
UZ - Uzbekistan 13
SA - Arabia Saudita 12
TN - Tunisia 12
AE - Emirati Arabi Uniti 11
BG - Bulgaria 11
PE - Perù 10
AL - Albania 9
IL - Israele 9
KE - Kenya 9
LB - Libano 9
NZ - Nuova Zelanda 9
BO - Bolivia 8
DK - Danimarca 8
JM - Giamaica 8
PY - Paraguay 8
QA - Qatar 8
CL - Cile 7
ET - Etiopia 7
SN - Senegal 7
TH - Thailandia 7
HR - Croazia 6
KZ - Kazakistan 6
UY - Uruguay 6
AZ - Azerbaigian 5
CI - Costa d'Avorio 5
IR - Iran 5
KW - Kuwait 5
MK - Macedonia 5
TW - Taiwan 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
GE - Georgia 4
HN - Honduras 4
HU - Ungheria 4
LV - Lettonia 4
NG - Nigeria 4
OM - Oman 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BH - Bahrain 3
LA - Repubblica Popolare Democratica del Laos 3
LU - Lussemburgo 3
NI - Nicaragua 3
PS - Palestinian Territory 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BY - Bielorussia 2
CG - Congo 2
Totale 44.022
Salva come PNG Salva come JPEG
Città #
Jacksonville 3.347
Chandler 2.675
Singapore 2.576
Dublin 2.531
San Jose 1.797
Dallas 1.369
Hong Kong 1.098
Ashburn 1.040
Santa Clara 1.003
Boardman 995
Izmir 831
Nanjing 554
The Dalles 526
San Mateo 512
Wilmington 495
Moscow 447
Lawrence 444
Princeton 444
New York 403
Beijing 371
Ann Arbor 291
Ho Chi Minh City 289
Lauterbourg 253
Nanchang 221
Hanoi 207
Amsterdam 176
Los Angeles 176
Milan 174
L'aquila 164
L’Aquila 162
Dearborn 142
Woodbridge 135
Seattle 131
Verona 122
Hefei 121
Shenyang 119
Des Moines 118
Hebei 103
Council Bluffs 100
São Paulo 94
Tokyo 94
Kunming 90
Tianjin 90
Jiaxing 84
Frankfurt am Main 80
Shanghai 79
Munich 78
Mountain View 65
Helsinki 62
Changsha 60
Dong Ket 60
Columbus 58
Brussels 57
Jinan 57
Zhengzhou 56
Norwalk 55
Rome 48
Hangzhou 43
Orem 43
Da Nang 40
Chicago 39
Phoenix 39
Haiphong 38
Pune 37
Montreal 35
Ningbo 34
Rio de Janeiro 34
Philadelphia 33
Houston 32
Warsaw 32
Guangzhou 31
Johannesburg 31
San Francisco 29
Brooklyn 28
London 28
Belo Horizonte 26
Chennai 26
Stockholm 25
Mumbai 24
Atlanta 23
Manchester 23
Toronto 23
Denver 21
Kitzingen 21
Lanzhou 21
Brno 19
New Delhi 19
Pescara 18
Bremen 17
Mexico City 17
Taizhou 17
Ankara 16
Boston 16
Redwood City 16
Brasília 15
Bucharest 15
Falkenstein 15
Baghdad 14
Changchun 14
Nuremberg 14
Totale 29.030
Salva come PNG Salva come JPEG
Nome #
------- 347
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 281
Studio dell’espressione della chemochina SDF-1 e del suo recettore CXCR4 nella cute e nelle cellule endoteliali microvascolari di pazienti affetti da sclerosi sistemica (SSc). 195
Aumento dei linfociti circolanti gamma-delta Vdelta1+ in corso di malattie infiammatorie intestinali 180
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 175
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 170
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 158
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 157
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 156
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 153
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 152
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 151
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 151
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 149
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 147
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 145
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: Results of a large multicentre study 138
Linfociti T Gamma-Delta (G/D) in pazienti con malattie infiammatorie intestinali (IBD) 138
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. 138
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 138
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 138
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 137
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 136
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 136
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 135
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 135
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 133
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 131
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 131
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 130
Cardiovascular disease in primary sjögren’s syndrome 130
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 130
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 129
T Regulatory and T Helper 17 Cells in Primary Sjögren's Syndrome: Facts and Perspectives. 129
Natural killer activity and antibody-dependent cellular cytotoxicity in progressive systemic sclerosis 129
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 127
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 127
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 126
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 126
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 125
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 125
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 125
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 125
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 124
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients with Sjögren's Syndrome: Comment on the Article by Nocturne et al 123
Interleukin (IL)-22 receptor 1 is over-expressed in primary Sjogren's syndrome and Sjögren-associated non-Hodgkin lymphomas and is regulated by IL-18. 122
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 121
Endothelial progenitor cells: Are they displaying a function in autoimmune disorders? 121
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 121
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 121
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 121
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 120
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 120
Association between a stromal cell-derived factor 1 (SDF-1/CXCL12) gene polymorphism and microvascular disease in systemic sclerosis 119
Stem cell therapies for systemic sclerosis 119
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 118
Malattie dell'apparato cardiovascolare 118
ALTERAZIONI DELLE SOTTOPOLAZIONI LINFOCITARIE IN CORSO DI SCLERODERMIA 118
SDF-1/CXCR4 system in microvascular endothelial cells and skin from patients affected by systemic sclerosi 117
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study 117
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 117
GM-CSF and pregnancy: evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment. 117
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 117
Diagnostic and interventional radiology fundamentals of synovial pathology 117
Comment on 'Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?' 116
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 116
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 116
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 116
Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization 115
Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis 115
Inosine pranobex in the combination therapy of HIV infection. 115
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 115
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 115
Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population. 115
Cytokine production in patients with monoclonal gammapathies. 115
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 114
 T cells in placenta and skin: their different functions may support the paradigm of microchimerism in systemic sclerosi 114
Peripheral blood mononuclear cells of patients with systemic sclerosis produce increased amounts of interleukin 6, but not transforming growth factor beta 1. 114
Biotech on the Rise: The Treatment of Psoriasis with Biological Drugs 114
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 114
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 114
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 113
Combined approach to the initial stage raynaud’s phenomenon diagnosis by means of dynamic digital telehermograpy, capillaroscopy and pletismography. Preliminary findings. 113
EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells 113
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 113
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 112
GAMMA/DELTA T CELL APOPTOSIS IN SYSTEMIC SCLEROSIS PATIENTS 112
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy 112
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 112
Gamma-delta T cells are not involved in the natural and antibody-dependent cytotoxicity of peripheral blood mononuclear cells in inflammatory bowel disease. 112
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 112
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 111
The expansion of NK CD56+ cells with reduced cytotoxicity in a female patient with systemic sclerosis 111
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 111
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 110
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 110
Interstitial lung disease in systemic sclerosis: current and future treatment. 110
Circulating soluble factor-inhibiting natural killer (NK) activity of fresh peripheral blood mononuclear cells (PBMC) from inflammatory bowel disease (IBD) patients 109
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 109
Vitamin D and systemic lupus erythematosus - The hype and the hope 109
Totale 12.989
Salva come PNG Salva come JPEG
Categoria #
all - tutte 187.267
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 187.267
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.074 0 0 0 0 0 0 0 0 0 129 758 187
2021/20222.529 134 240 441 174 103 26 21 152 189 131 179 739
2022/20237.628 605 368 158 745 734 854 15 537 3.241 57 213 101
2023/20241.937 418 114 116 257 149 476 33 103 10 81 52 128
2024/20257.471 135 151 757 232 840 631 975 632 1.824 304 480 510
2025/202612.428 692 1.366 712 1.557 1.195 1.175 2.629 594 1.388 1.120 0 0
Totale 44.517